biotech Archives - Iran News Daily

Biotech holds 40% share of pharmaceutical exports

mahla — Sun, 18 Sep 2022 20:37:18 +0000

TEHRAN (Iran News) –Some 40 percent of the country’s total pharmaceutical exports are biotechnology products, a member of the board of directors of the Association of Manufacturers and Exporters of Medical Biotechnology Products, has said.

Self-sufficiency in the production of these products is unique compared to other countries in the world, Bardia Farzanfar added.

He went on to explain that biotechnology refers to the use of living systems and organisms to develop products or any technological application that uses biological systems, organisms, or their derivatives to create or modify certain products or processes.

The production costs of biotechnology products are different from chemical drugs and have brought 10 times foreign exchange savings for the country, and many knowledge-based companies have achieved self-sufficiency in the production of these products without depending on other countries.

Iran’s biotechnology products are exported to European, Asian, and Latin American countries, and Iran’s technology can compete with other countries in this field, he further highlighted.

About 80 percent of biotechnology molecules are produced in the country, and we are the second country in the world in the production of these products.

“We are also self-sufficient in the production of products derived from plasma, and we have designed and established the formula of these products,” he said.

There are more than 500 knowledge-based companies active in the field of biotechnology, and about 16 companies operate in the field of medicine.

Biotechnology development

Currently, 20 to 30 types of biotech medicine are produced in the country in addition to kits, vaccines, and blood products. Also, 80 percent of biotechnology pharmaceutical items are domestically produced.

Iran’s biotechnology products are exported to European, Asian, and Latin American countries. Biotechnology today is widespread in all fields and is no longer limited to biomedical drugs so it has replaced the injured limbs.

The Vice Presidency for Science and Technology is set to achieve a 3 percent share of the global biotechnology market.

In May 2021, the Biotechnology Development Council launched 129 production projects with the aim of saving up to $1.44 billion in foreign currency.

Iran is ranked 12th in the world and first in West Asia in terms of biotechnology, as 9.5 percent of the income of knowledge-based companies and more than 60 percent of their exports are related to biotechnology.

Foreign exchange savings of $1 billion per year by producing 22 biopharmaceuticals, gaining the first rank in biotechnology products and vaccines in West Asia, and the presence among the top five biotechnology producers in Asia are among the country’s achievements, Mostafa Ghanei, secretary of the biotechnology development office of the Vice Presidency for Science and Technology, said in October 2020.

So far, 27 biotechnology medicines, 12 vaccine projects, 90 pharmaceutical raw materials, and 55 projects in agriculture and food security have been implemented in order to gain a 3 percent market share and biotechnology assistance to the development of the economy, he explained.

The post Biotech holds 40% share of pharmaceutical exports appeared first on Iran News Daily.

10 new biotech. drugs to enter market in 3 years: Ghanei

reporter 1222 — Mon, 04 Feb 2019 08:04:29 +0000

Chairman of the Biotechnology Development Council said Mon. that the country has obtained the technical know-how for production of 10 new biopharmaceuticals, which will be produced and enter the market in two or three years.

Mostafa Ghanei, Chairman of the Biotechnology Development Council, told Mehr News correspondent on Monday that in the past years, 22 biopharmaceuticals have entered the country’s market, deeming it a good progress for Iran considering the heavy sanctions imposed on the country and on all biotechnology equipment.

He said Iran is unrivaled in the region in the field of biotechnology.

“According to the Twenty Year National Vision (Vision 2025), we need to have claimed first place in the region in biotechnology in six years. We have already achieved that ranking and we are ahead of the schedule,” he said.

“We aim to become number one in Asia in terms of biopharmaceutical production. At the moment, we are ranked second after Japan,” he added.

Ghanei further maintained that the country has obtained the technical know-how for the production of ten new biopharmaceuticals, which will enter the market in two or three years. He added that with support given to the drugs produced this year, the country can maintain its second place or improve it to the first place in Asia under a five or six year plan.

The post 10 new biotech. drugs to enter market in 3 years: Ghanei appeared first on Iran News Daily.

Iranian biotech drugs replaced American ones in Russia

reporter 1222 — Tue, 12 Sep 2017 08:03:12 +0000

TEHRAN – Iranian biotech medicines exported to Russia have taken over the country’s market 100% and have replaced their American versions, according to National Talents Foundation.

Meanwhile, Iran’s status in the field of knowledge-based and innovative economy has leaped 42 places in global indexes in 2016 and reached 78th place from 120th in 2014.

Drug registration requires performing clinical trials. The Iranian biotech medicines have undergone clinical trials for three years until they obtained approvals from Russia.

For the first time, two Iranian bio drugs are undergoing registration process in Europe. Meanwhile, five Iranian bio medicines have already been registered in Russia and completely replaced their American versions in the Russian market.

One of the exported medicines to Russia is a drug used in treatment of Multiple sclerosis (MS). The anti-cancer drug has recently received approval and is being currently exported. Furthermore, the export of Iranian medicines to Iraq and Turkey has gone underway following the same process.

The post Iranian biotech drugs replaced American ones in Russia appeared first on Iran News Daily.